Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.

Heart (British Cardiac Society) - 1 Jul 2011

Nherera L, Marks D, Minhas R, Thorogood M, Humphries S E

Abstract excerpt

OBJECTIVE: To estimate the probabilistic cost-effectiveness of cascade screening methods in familial hypercholesterolaemia (FH) from the UK NHS perspective. DESIGN: Economic evaluation (cost utility analysis) comparing four cascade screening strategies for FH: Using low-density lipoprotein (LDL) cholesterol measurements to diagnose affected relatives (cholesterol method); cascading only in patients with a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Quality-Adjusted Life Years
Share to Cost-Benefit Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Costs

Share to False Negative Reactions

Share to False Positive Reactions

Share to Health Care Costs

Share to Hydroxymethylglutaryl-CoA Reductase Inhibitors

Share to Models, Economic

Source

Identifiers

PMID: 21685482
DOI: 10.1136/hrt.2010.213975

Genes

NHS

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Probabilistic cost-effectiveness analysis of cascade screening for familial hypercholesterolaemia using alternative diagnostic and identification strategies.PMID 21685482Read ↗

Universal screening at age 1-2 years as an adjunct to cascade testing for familial hypercholesterolaemia in the UK: A cost-utility analysis.Semantic proximity Read ↗

Cost-utility analysis of searching electronic health records and cascade testing to identify and diagnose familial hypercholesterolaemia in England and Wales.Semantic proximity Read ↗

Cost-effectiveness of alternative cascade screening strategies for familial hypercholesterolemia with realistic cascade screening acceptance rates and use of novel treatment.Semantic proximity Read ↗

Cost-effectiveness of alternative cascade screening strategies for familial hypercholesterolemia with realistic cascade screening acceptance rates and use of high-cost drugsSemantic proximity Read ↗

Cascade screening amplifies familial hypercholesterolaemia detection after clinically guided next- generation sequencingSemantic proximity Read ↗

Effectiveness of genetic cascade screening for familial hypercholesterolaemia using a centrally co-ordinated clinical service: an Australian experience.Semantic proximity Read ↗

Cost-effectiveness of cascade genetic testing for familial hypercholesterolemia in the United States: A simulation analysisSemantic proximity Read ↗

A cost-effectiveness model of genetic testing and periodical clinical screening for the evaluation of families with dilated cardiomyopathySemantic proximity Read ↗

Reaching detection targets in familial hypercholesterolaemia: Comparison of identification strategies.Semantic proximity Read ↗

Estimating the efficacy and efficiency of cascade genetic screening.Semantic proximity Read ↗

Integrating provision of specialist lipid services with cascade testing for familial hypercholesterolaemiaSemantic proximity Read ↗

Cascade screening for familial hypercholesterolaemia: implications of a pilot study for national screening programmes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.